Phase 1 clinical trial of BLU-782 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 04 Jan 2019
At a glance
- Drugs BLU-782 (Primary)
- Indications Fibrodysplasia ossificans progressiva
- Focus Adverse reactions
- 04 Jan 2019 According to a Blueprint Medicines media release, this trial is anticipated to begin in the first half of 2020.
- 08 Oct 2018 New trial record
- 01 Oct 2018 According to a Blueprint Medicines media release, company expects to submit an investigational new drug (IND) by the end of 2018.